Alcedis GmbH stands for long years of CRO experience and profound expertise in the conduct of clinical trials. One focal point distinguishing Alcedis is our innovative software systems constitute a centrepiece of the Alcedis trademark.

Our module-based service concept adjusts itself flexibly to your project structure. Likewise individually adapted are our data entry and software systems.

With our network of qualified partners, we conduct national or international phase I to IV multi-center studies, non-interventional studies and registers for medicinal products and medical devices.

 

 

 

 





08.01.2020 / Imputation/Missing Data
Missing values among collected data are not uncommon and there are several different reasons for their occurrence, some of which are inevitable. Performing a thought-out imputation can help to obtain reliable statistical results even for high rates of missing values. In this article we are trying to give a basic understanding on the topic by having a look at what imputation means at all,...
07.02.2019 - Alcedis Supportteam
At Alcedis, we try to care best for your questions and inquiries! Thus, we decided to reorganize our support and helpdesk team.   Via telephone number +49 (0)641 / 944 36 36 and email address support@alcedis.de, you will reach our Alcedis Support Hotline. Please choose this number/email address for all study specific questions, e.g.   Where do I find the eCRF/databas...
Alcedis Christmas Fundraiser achieved record sum
In this year’s Christmas game you have supported the ‘Happy Alcedo’, our little logo bird, on his adventurous flight route collecting small gift packages and thus achieved a new record sum! 4.009 € - as much as never before – were won for non-profit organizations such as:   die Deutsche Kinderkrebsstiftung  DKMS Mèdecins Sans Frontières WWF Greenpeace NA...
2. August 2018 - European Melanoma Registry (EuMelaReg)
Capture of real-world data of treating melanoma patients across Europe   The collection and evaluation of real-world data is of particular importance for the further development of treatment strategies, clinical guidelines and future innovation for prevention, diagnosis and treatment of cancer.   In approval studies the application of study medication is recorded...
e2b (R3) -Let’s think beyond...
For years electronic exchange of ICSRs with the EudraVigilance database in an e2b-compliant standard has become mandatory for all MAHs of medicinal products. However, ICSRs from the CRO’s clinical database to the MAHs in both, non-interventional studies and clinical trials, are still transmitted paper-based or in electronic portable document format (pdf).   The benefits of using ...

 

Facts

+20
Years of Experience
+143
Employees
+420.000
Patients
+400
Projects
49
Countries
5.213.542
Lines software code

Partner and References

Our clients and partner are at home all over this globe. Check out a choice of references.